Cost-utility of interferon β1bin the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis

✍ Scribed by G. Kobelt; L. Jönsson; S. Fredrikson

• Publisher: Springer
• Year: 2003
• Tongue: French
• Weight: 346 KB
• Volume: 4
• Category: Article
• ISSN: 1618-7598
• DOI: 10.1007/s10198-002-0163-0